Munemura, R., Maehara, T., Murakami, Y., Koga, R., Aoyagi, R., Kaneko, N., Doi, A., Perugino, C. A., Della-Torre, E., Saeki, T., Sato, Y., Yamamoto, H., Kiyoshima, T., Stone, J. H., Pillai, S., & Nakamura, S. (2022). Distinct disease-specific Tfh cell populations in 2 different fibrotic diseases: IgG4-related disease and Kimura disease. Journal of Allergy and Clinical Immunology, 150(2), 440-455.e17. https://doi.org/10.1016/j.jaci.2022.03.034
Yokoyama, K., Mitoma, H., Kawano, S., Yamauchi, Y., Wang, Q., Ayano, M., Kimoto, Y., Ono, N., Arinobu, Y., Akashi, K., Horiuchi, T., & Niiro, H. (2022). CEACAM 1, 3, 5 and 6 -positive classical monocytes correlate with interstitial lung disease in early systemic sclerosis. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.1016914
Hatano, S., Mine, K., Noguchi, N., Matsumoto, M., Baba, Y., & Yoshikai, Y. (2022). MHC class II inhibits the generation of IL‐17A + Vγ6 γδ T cells in the thymus at perinatal stage. European Journal of Immunology, 52(8), 1366–1368. https://doi.org/10.1002/eji.202149542
Kanemura, H., Hayashi, H., Tomida, S., Tanizaki, J., Suzuki, S., Kawanaka, Y., Tsuya, A., Fukuda, Y., Kaneda, H., Kudo, K., Takahama, T., Imai, R., Haratani, K., Chiba, Y., Otani, T., Ito, A., Sakai, K., Nishio, K., & Nakagawa, K. (2022). The Tumor Immune Microenvironment and Frameshift Neoantigen Load Determine Response to PD-L1 Blockade in Extensive-Stage SCLC. JTO Clinical and Research Reports, 3(8), 100373. https://doi.org/10.1016/j.jtocrr.2022.100373
Miyata, N., Ito, T., Nakashima, M., Fujii, S., & Kuge, O. (2022). Mitochondrial phosphatidylethanolamine synthesis affects mitochondrial energy metabolism and quiescence entry through attenuation of Snf1/AMPK signaling in yeast. The FASEB Journal, 36(7). https://doi.org/10.1096/fj.202101600RR
Shinkawa, T., Ohuchida, K., Mochida, Y., Sakihama, K., Iwamoto, C., Abe, T., Ideno, N., Mizuuchi, Y., Shindo, K., Ikenaga, N., Moriyama, T., Nakata, K., Oda, Y., & Nakamura, M. (2022). Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses. Journal of Experimental & Clinical Cancer Research, 41(1), 89. https://doi.org/10.1186/s13046-022-02301-9
Otsuka, H., Yokomizo, H., Nakamura, S., Izumi, Y., Takahashi, M., Obara, S., Nakao, M., Ikeda, Y., Sato, N., Sakamoto, R., Miyachi, Y., Miyazawa, T., Bamba, T., & Ogawa, Y. (2022). Differential effect of canagliflozin, a sodium–glucose cotransporter 2 (SGLT2) inhibitor, on slow and fast skeletal muscles from nondiabetic mice. Biochemical Journal, 479(3), 425–444. https://doi.org/10.1042/BCJ20210700
